India: Food, Drugs, Healthcare, Life Sciences

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
A Drug Pill Which Could Change How Medicines Will Be Priced Forever
Assume your doctor prescribes a drug to you. The brand-name version costs $300 a month. Another generic drug on the other hand will cost $30. As most people would, you would also purchase the cheaper one. That generic cheaper bottle exists as a result of a delicate legal balancing act, an act that the U.S. Supreme Court is now reconsidering in a case that could change pharmaceutical competition for decades.
India Healthcare
LegaLogic
Article
FSSAI Proposes Plastic-Free Packaging Mandate For Pan Masala: An Analysis Of The Draft Food Safety And Standards (Packaging) Amendment Regulations, 2026
The Food Safety and Standards Authority of India has proposed amendments to packaging regulations that would mandate pan masala manufacturers to abandon plastic-based packaging in favor of paper, cellulose, tin, or glass materials. This regulatory intervention harmonizes food safety standards with environmental protection mandates by incorporating provisions from the Plastic Waste Management Rules, 2016, creating a comprehensive framework that addresses both public health and sustainability concerns. The dr
India Healthcare
IL
IndiaLaw LLP
See more

Food and Drugs Law

Article
A Drug Pill Which Could Change How Medicines Will Be Priced Forever
Assume your doctor prescribes a drug to you. The brand-name version costs $300 a month. Another generic drug on the other hand will cost $30. As most people would, you would also purchase the cheaper one. That generic cheaper bottle exists as a result of a delicate legal balancing act, an act that the U.S. Supreme Court is now reconsidering in a case that could change pharmaceutical competition for decades.
India Healthcare
LegaLogic
Article
Failure To Conduct Enquiry Under Section 202 Of The Code Of Criminal Procedure, 1973 Does Not Vitiate Complaint Filed By Public Servant; Limitation Runs From Discovery Of Offender
The Supreme Court of India (“Supreme Court”) in the case of The State of Kerala vs. M/s Panacea Biotec Limited and Anr. considered whether criminal proceedings under the Drugs and Cosmetics Act, 1940 could be quashed on the ground that the Magistrate failed to conduct an enquiry under Section 202 of the Code of Criminal Procedure, 1973 (“CrPC”), and whether cognisance was barred by limitation under Sections 468 and 469 of the CrPC.
India Litigation
J
JSA
See more

Life Sciences, Biotechnology & Nanotechnology

See more

Healthcare

Article
A Drug Pill Which Could Change How Medicines Will Be Priced Forever
Assume your doctor prescribes a drug to you. The brand-name version costs $300 a month. Another generic drug on the other hand will cost $30. As most people would, you would also purchase the cheaper one. That generic cheaper bottle exists as a result of a delicate legal balancing act, an act that the U.S. Supreme Court is now reconsidering in a case that could change pharmaceutical competition for decades.
India Healthcare
LegaLogic
See more

Latest Videos

See more